Cytosorbents Corp
CTSO
79 hedge funds and large institutions have $106M invested in Cytosorbents Corp in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 9 closing their positions.
268% more call options, than puts
Call options by funds: $776K | Put options by funds: $211K
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
18% more capital invested
Capital invested by funds: $89.2M → $106M (+$16.5M)
18% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 22
5% more funds holding
Funds holding: 75 → 79 (+4)
0.06% less ownership
Funds ownership: 26.11% → 26.06% (-0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.2M |
| 2 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$2.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$2.39M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.35M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.63M |
| 2 |
Two Sigma Investments
New York
|
-$2.23M |
| 3 |
JP Morgan Chase
New York
|
-$1.25M |
| 4 |
Two Sigma Advisers
New York
|
-$575K |
| 5 |
Millennium Management
New York
|
-$501K |
CTSO Hedge Fund Activity: Q3 2018 in Review
79 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2018, worth a combined $106M — up 18% from $89.2M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CTSO positions and 9 closed out — a net gain of 5 holders — while 26 added to existing stakes and 22 trimmed.
The largest buyer was BlackRock, adding an estimated $3.2M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.63M sold.
- 79 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2018, up from 75 in Q2 2018.
- Funds reported $106M of Cytosorbents Corp stock for Q3 2018, up 18% quarter-over-quarter.
- 14 funds opened new Cytosorbents Corp positions in Q3 2018 and 9 closed out, a net change of +5 holders.
- The largest Cytosorbents Corp buyer in Q3 2018 was BlackRock, an estimated $3.2M added.
- The largest Cytosorbents Corp seller in Q3 2018 was Renaissance Technologies, an estimated $2.63M sold.
Based on aggregated 13F filings for Q3 2018.